ConductScience.org, home

Paper30441908

sdAb-DB: The Single Domain Antibody Database.

Wilton EE and 4 others. ACS Synth Biol, 2018. Cited by 64 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. sdAb-DB: The Single Domain Antibody Database. Papers, record 30441908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30441908

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
sdAb-DB: The Single Domain Antibody Database.
PubMed
Journal
ACS Synth Biol
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
2.44
iCite
Revised in PubMed
2019-10-07
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wilton EEEmily E
2Opyr MPMichael P
3Kailasam SSenthilkumar
4Kothe RFRonja F
5Wieden HJHans-Joachimhttps://orcid.org/0000-0001-5181-6059

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Databases, ProteinMajor topic
Single-Domain AntibodiesMajor topic
Bioengineering
Synthetic Biology
User-Computer Interface

Source PubMed

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
42,939,733Artificial Intelligence-Driven Nanobody Engineering for Pathogen Recognition: From Functional Epitope Prioritization to Multimodal Foundation Models.Biomolecules2026https://conductscience.org/library/papers/42939733PubMed
42,824,780Beyond affinity: AI-supported developability assessment and multi-objective optimization in antibody development.Antib Ther2026https://conductscience.org/library/papers/42824780PubMed
42,344,233NanoBind: Mechanism-Driven Deep Learning of Nanobody-Antigen Molecular Recognition.Research (Wash D C)2026https://conductscience.org/library/papers/42344233PubMed
41,808,445Predicting antibody-antigen affinity with a dual-level representation model.Bioinformatics2026https://conductscience.org/library/papers/41808445PubMed
41,723,205A Unified Dataset for Antibody and Nanobody Design Including Sequence, Structure, and Binding Affinity Data.Sci Data2026https://conductscience.org/library/papers/41723205PubMed
41,660,941RASP: rapid antibody functional screening by pentavalent phage display.MAbs2026https://conductscience.org/library/papers/41660941PubMed
41,440,489Species-Dependent Structural Variations in Single-Domain Antibodies.Antibodies (Basel)2025https://conductscience.org/library/papers/41440489PubMed
40,533,487A three dimensional immunolabeling method with peroxidase-fused nanobodies and fluorochromized tyramide-glucose oxidase signal amplification.Commun Biol2025https://conductscience.org/library/papers/40533487PubMed
40,427,503Small but Mighty: Nanobodies in the Fight Against Infectious Diseases.Biomolecules2025https://conductscience.org/library/papers/40427503PubMed
39,915,791Unveiling the new chapter in nanobody engineering: advances in traditional construction and AI-driven optimization.J Nanobiotechnology2025https://conductscience.org/library/papers/39915791PubMed
39,688,476NABP-BERT: NANOBODY®-antigen binding prediction based on bidirectional encoder representations from transformers (BERT) architecture.Brief Bioinform2024https://conductscience.org/library/papers/39688476PubMed
39,027,650A comprehensive overview of recent advances in generative models for antibodies.Comput Struct Biotechnol J2024https://conductscience.org/library/papers/39027650PubMed
38,960,409Antibody design using deep learning: from sequence and structure design to affinity maturation.Brief Bioinform2024https://conductscience.org/library/papers/38960409PubMed
38,898,362Nanobody engineering: computational modelling and design for biomedical and therapeutic applications.FEBS Open Bio2025https://conductscience.org/library/papers/38898362PubMed
38,681,780Physicochemical differences between camelid single-domain antibodies and mammalian antibodies.Turk J Biol2023https://conductscience.org/library/papers/38681780PubMed
38,300,518NanoLAS: a comprehensive nanobody database with data integration, consolidation and application.Database (Oxford)2024https://conductscience.org/library/papers/38300518PubMed
38,162,639Advances in research based on antibody-cell conjugation.Front Immunol2023https://conductscience.org/library/papers/38162639PubMed
37,957,563DG-Affinity: predicting antigen-antibody affinity with language models from sequences.BMC Bioinformatics2023https://conductscience.org/library/papers/37957563PubMed
37,781,019Characterization of Foot-and-Mouth Disease Virus Serotype O-Specific Single Domain Antibody Expressed in the pET Expression System.Indian J Microbiol2023https://conductscience.org/library/papers/37781019PubMed
37,418,494Bypassing the Need for Cell Permeabilization: Nanobody CDR3 Peptide Improves Binding on Living Bacteria.Bioconjug Chem2023https://conductscience.org/library/papers/37418494PubMed

See all 49 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30441908

GET https://conductscience.org/api/papers/v1/30441908/cited_by?page=2